Evolus Inc. (EOLS)

Trade EOLS now with
10/1/2019 9:13:39 AM Evolus Gets Approval For Nuceiva In EU
7/15/2019 8:43:30 AM Evolus Appoints Independent Directors Peter Farrell And Karah Parschauer
11/19/2018 5:42:12 AM Evolus Receives Conditional FDA Acceptance Of Jeuveau Brand Name
11/5/2018 4:08:43 PM Evolus Q3 Loss/share $0.48 Vs. Loss $0.16 Year Ago
10/22/2018 4:09:10 PM Evolus Names Kurt Knab VP Of Sales, Alejandro Sabad VP Of Operations And Amy Marinne Fox VP Of Human Resources
9/5/2018 8:07:10 AM Evolus Appoints Ashwin Agarwal As VP, Finance, Investor Relations And Treasury
8/29/2018 8:02:06 AM Evolus Gets Acceptance Of FDA BLA Resubmission For DWP-450
8/17/2018 8:05:14 AM Evolus Granted Approval Of DWP-450 By Health Canada
8/2/2018 7:45:08 AM Evolus Q2 Net Loss $16.4 Mln Or $0.69/Shr Vs Net Loss $2.3 Mln Or $0.14/Shr Last Year
8/2/2018 7:26:31 AM Evolus Announces Early Resubmission To The FDA Of Its Biologics License Application For DWP-450
7/18/2018 10:34:42 PM Evolus Prices Public Offering Of 4 Mln Shares At $20.00/shr